Gregory W. Adams

Array ( [id] => 5422442 [patent_doc_number] => 20090148897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Human Ron-Related Gene Variant Associated With Cancers' [patent_app_type] => utility [patent_app_number] => 12/209133 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 6401 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148897.pdf [firstpage_image] =>[orig_patent_app_number] => 12209133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515525 [patent_doc_number] => 08039597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Antibodies and related molecules that bind to 24P4C12 proteins' [patent_app_type] => utility [patent_app_number] => 12/205560 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 113 [patent_figures_cnt] => 235 [patent_no_of_words] => 70941 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039597.pdf [firstpage_image] =>[orig_patent_app_number] => 12205560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948981 [patent_doc_number] => 20080305107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE' [patent_app_type] => utility [patent_app_number] => 12/187221 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 38870 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305107.pdf [firstpage_image] =>[orig_patent_app_number] => 12187221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290011 [patent_doc_number] => 20090022741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE' [patent_app_type] => utility [patent_app_number] => 12/187240 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 38876 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022741.pdf [firstpage_image] =>[orig_patent_app_number] => 12187240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520898 [patent_doc_number] => 20090028879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE' [patent_app_type] => utility [patent_app_number] => 12/187232 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 38876 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028879.pdf [firstpage_image] =>[orig_patent_app_number] => 12187232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545398 [patent_doc_number] => 20090155275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'MULTISPECIFIC EPITOPE BINDING PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/182975 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 85682 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155275.pdf [firstpage_image] =>[orig_patent_app_number] => 12182975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4441333 [patent_doc_number] => 07927834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Recombinant production of mixtures of antibodies' [patent_app_type] => utility [patent_app_number] => 12/221021 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 36 [patent_no_of_words] => 34055 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/927/07927834.pdf [firstpage_image] =>[orig_patent_app_number] => 12221021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555647 [patent_doc_number] => 08067548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Fusion proteins having mutated immunoglobulin hinge region' [patent_app_type] => utility [patent_app_number] => 12/180455 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12722 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067548.pdf [firstpage_image] =>[orig_patent_app_number] => 12180455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5289932 [patent_doc_number] => 20090022662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 12/172645 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14509 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022662.pdf [firstpage_image] =>[orig_patent_app_number] => 12172645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5295922 [patent_doc_number] => 20090010848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody Peptides' [patent_app_type] => utility [patent_app_number] => 12/143648 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 19436 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010848.pdf [firstpage_image] =>[orig_patent_app_number] => 12143648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228864 [patent_doc_number] => 20100183602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Induction of Tolerogenic Phenotype in Mature Dendritic Cells' [patent_app_type] => utility [patent_app_number] => 12/663431 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17019 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183602.pdf [firstpage_image] =>[orig_patent_app_number] => 12663431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330665 [patent_doc_number] => 20090111142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Method for manufacturing a recombinant polyclonal protein' [patent_app_type] => utility [patent_app_number] => 12/153809 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21584 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111142.pdf [firstpage_image] =>[orig_patent_app_number] => 12153809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478970 [patent_doc_number] => 20100092455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'NOVEL ANTI-PROLIFERATION ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/125726 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 24722 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092455.pdf [firstpage_image] =>[orig_patent_app_number] => 12125726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 103120 [patent_doc_number] => 07723485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates' [patent_app_type] => utility [patent_app_number] => 12/116457 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 39303 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723485.pdf [firstpage_image] =>[orig_patent_app_number] => 12116457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391207 [patent_doc_number] => 20090208520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'PRRSV GP5 BASED COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/111871 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 75 [patent_figures_cnt] => 75 [patent_no_of_words] => 14367 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208520.pdf [firstpage_image] =>[orig_patent_app_number] => 12111871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6449871 [patent_doc_number] => 20100145023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Optimized Nucleotide Sequences of VB6-845 For Expression of Recombinant Proteins' [patent_app_type] => utility [patent_app_number] => 12/596188 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5116 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20100145023.pdf [firstpage_image] =>[orig_patent_app_number] => 12596188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543619 [patent_doc_number] => 08318911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Anti-EpCAM antibody and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/594559 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8549 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820421 [patent_doc_number] => 20080226629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'ANTI-VEGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/056724 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30265 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226629.pdf [firstpage_image] =>[orig_patent_app_number] => 12056724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5454853 [patent_doc_number] => 20090070890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Product' [patent_app_type] => utility [patent_app_number] => 12/055743 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24121 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20090070890.pdf [firstpage_image] =>[orig_patent_app_number] => 12055743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718615 [patent_doc_number] => 20080241137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 12/055014 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14529 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241137.pdf [firstpage_image] =>[orig_patent_app_number] => 12055014 [rel_patent_id] =>[rel_patent_doc_number] =>)